Jeffrey Swigris
- Effect of design modifications on trial outcomes in idiopathic pulmonary fibrosis (IPF): Analysis of data from ASCEND and CAPACITY (CAP)By Talmadge King, Williamson Bradford, Socorro Castro-Bernardini, Elizabeth Fagan, Ian Glaspole, Marilyn Glassberg, Eduard Gorina, Peter Hopkins, David Kardatzke, Lisa Lancaster, David Lederer, Steven Nathan, Carlos Pereira, Steven Sahn, Robert Sussman, Jeffrey Swigris and Paul NobleTalmadge King1Medicine, University of California, San Francisco, San Francisco, CA,Williamson Bradford2Clinical Research, Intermune Inc, Brisbane, CA,Socorro Castro-Bernardini3Neumocare, Clínica San Borja, Lima, PeruElizabeth Fagan2Clinical Research, Intermune Inc, Brisbane, CA,Ian Glaspole4Medicine, Alfred Hospital, Melbourne, AustraliaMarilyn Glassberg5Medicine, University of Miami Miller School of Medicine, Miami, FL,Eduard Gorina2Clinical Research, Intermune Inc, Brisbane, CA,Peter Hopkins6Medicine, Prince Charles Hospital, Brisbane, QLD, AustraliaDavid Kardatzke2Clinical Research, Intermune Inc, Brisbane, CA,Lisa Lancaster7Medicine, Vanderbilt University Medical Center, Nashville, TN,David Lederer8Medicine, Columbia University Medical Center, New York, NY,Steven Nathan9Medicine, Inova Fairfax Hospital, Falls Church, VA,Carlos Pereira10Medicine, Paulista School of Medicine, Federal University of Sao Paulo, Sao Paolo, BrazilSteven Sahn11Medicine, Medical University of South Carolina, Charleston, SC,Robert Sussman12Medicine, Pulmonary and Allergy Associates, Summit, NJ,Jeffrey Swigris13Medicine, National Jewish Health, Denver, CO,Paul Noble14Medicine, Cedars-Sinai Medical Center, Los Angeles, CA,
- Benefit of continued pirfenidone treatment following hospitalisation within the first 6 months of therapy—Ad hoc analysis from three phase 3 trials in patients with idiopathic pulmonary fibrosis (IPF)By Steven Nathan, Carlo Albera, Williamson Bradford, Ulrich Costabel, Roland Du Bois, Elizabeth Fagan, Robert Fishman, Ian Glaspole, Marilyn Glassberg, Kenneth Glasscock, Lisa Lancaster, David Lederer, Zhengning Lin, Carlos Pereira, Jeffrey Swigris, Dominique Valeyre, Paul Noble and Athol WellsSteven Nathan1Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, United StatesCarlo Albera2Department of Clinical and Biological Sciences, University of Turin, Turin, ItalyWilliamson Bradford3Research and Development, Intermune Inc, Brisbane, CA United StatesUlrich Costabel4Department of Pneumology, Ruhrlandklinik, Essen, GermanyRoland Du Bois5Department of Respiratory Medicine, Imperial College, London, United KingdomElizabeth Fagan3Research and Development, Intermune Inc, Brisbane, CA United StatesRobert Fishman3Research and Development, Intermune Inc, Brisbane, CA United StatesIan Glaspole6Department of Immunology, Alfred Hospital and Monash University, Melbourne, AustraliaMarilyn Glassberg7Department of Pulmonology, University of Miami Miller School of Medicine, Miami, United StatesKenneth Glasscock3Research and Development, Intermune Inc, Brisbane, CA United StatesLisa Lancaster8Department of Medicine, Vanderbilt University Medical Center, Nashville, United StatesDavid Lederer9Department of Clinical Medicine, Columbia University Medical Center, New York, United StatesZhengning Lin3Research and Development, Intermune Inc, Brisbane, CA United StatesCarlos Pereira10Department of Medicine, Paulista School of Medicine, Federal University of São Paulo, São Paulo, BrazilJeffrey Swigris11Department of Medicine, National Jewish Health, Denver, United StatesDominique Valeyre12Service de Pneumologie, Assistance Publique-Hôpitaux de Paris, Avicenne University Hospital, Bobigny, FrancePaul Noble13Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United StatesAthol Wells14Department of Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.